An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder

Update Il y a 4 ans
Reference: NCT00360126

Woman and Man

  • | Country :
  • Australia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The precursor study (SCA101469) was an open-label, prospective multicentre study in adult subjects diagnosed with bipolar disorder consisting of 36 weeks treatment with lamotrigine. The current study is to provide 12 months post study access to open-label lamotrigine for participants of the SCA101469 study.


Inclusion criteria

  • Bipolar disorder

Links